Skip to main content
Top
Published in: International Urology and Nephrology 1/2009

01-03-2009 | Case report

Recurrent atrioventricular nodal re-entrant tachycardia treated with percutaneous ablation in a 75-year old patient undergoing intermittent hemodialysis

Authors: Aniela M. Ratajewska, Wojciech W. Banachowicz, Alicja E. Grzegorzewska

Published in: International Urology and Nephrology | Issue 1/2009

Login to get access

Abstract

A 75-year old man with long-term arterial hypertension was diagnosed in 1998 with stage 3 chronic kidney disease due to hypertensive nephropathy. Since May 2004 the patient has been treated with intermittent hemodialysis. Since 1998 he has been hospitalized several times because of palpitations in the course of paroxysmal tachycardia with narrow QRS complexes. Initially, class I antiarrhythmic agents were administered; afterwards therapy with beta-adrenolytics was introduced. Because of the ineffectiveness of monotherapy, beta-adrenolytic therapy was combined with amiodarone; however, side effects of this treatment in a form of drug-induced bradycardia appeared. During an invasive electrophysiological investigation, a typical recurrent atrioventricular nodal reentrant tachycardia (AVNRT) was repeatedly released. Subsequently performed percutaneous ablation resulted in effective modification of the slow pathway. During 25 months of follow up after the procedure, recurrence of AVNRT was not observed. Effectiveness of ablation and low risk of adverse effects in non-dialyzed patients encourage us to recommend this method of AVNRT treatment also in patients undergoing intermittent hemodialysis.
Literature
1.
go back to reference Koźluk E, Walczak F, Szufladowicz E et al (1997) Types of a–v node curve: characteristic in patients with atrio-nodal reentrant tachycardia. In: Oto A (ed) “EuroPacé97” Monduzzi Editore, International proceedings division, pp 293–297 Koźluk E, Walczak F, Szufladowicz E et al (1997) Types of a–v node curve: characteristic in patients with atrio-nodal reentrant tachycardia. In: Oto A (ed) “EuroPacé97” Monduzzi Editore, International proceedings division, pp 293–297
2.
go back to reference Li YG, Bender B, Bogun F et al (2000) Location of the lower turnaround point in typical AV nodal reentrant tachycardia: a quantitative model. J Cardiovasc Electrophysiol 11:34–40PubMedCrossRef Li YG, Bender B, Bogun F et al (2000) Location of the lower turnaround point in typical AV nodal reentrant tachycardia: a quantitative model. J Cardiovasc Electrophysiol 11:34–40PubMedCrossRef
3.
go back to reference McGuire M, Janse M, Ross D (1993) “AV nodal” reentry: Part II: AV nodal, AV junctional, or atrionodal reentry? J Cardiovasc Electrophysiol 4:573–586PubMedCrossRef McGuire M, Janse M, Ross D (1993) “AV nodal” reentry: Part II: AV nodal, AV junctional, or atrionodal reentry? J Cardiovasc Electrophysiol 4:573–586PubMedCrossRef
4.
go back to reference Inoue S, Becker AE (1998) Posterior extensions of the human compact atrioventricular node: a neglected anatomic feature of potential clinical significance. Circulation 97:188–193PubMed Inoue S, Becker AE (1998) Posterior extensions of the human compact atrioventricular node: a neglected anatomic feature of potential clinical significance. Circulation 97:188–193PubMed
5.
go back to reference Kozłowski D (1999) Morfologia łącza przedsionkowo – komorowego w aspekcie powstawania zaburzeń przewodzenia i krążącego pobudzenia. Dissertation, Medical University of Gdańsk Kozłowski D (1999) Morfologia łącza przedsionkowo – komorowego w aspekcie powstawania zaburzeń przewodzenia i krążącego pobudzenia. Dissertation, Medical University of Gdańsk
6.
go back to reference Kozłowski D, Koźluk E, Adamowicz M et al (1998) Histological examination of the topography of the atrioventricular node artery within the triangle of Koch. PACE 21:163–167PubMed Kozłowski D, Koźluk E, Adamowicz M et al (1998) Histological examination of the topography of the atrioventricular node artery within the triangle of Koch. PACE 21:163–167PubMed
7.
go back to reference Koźluk E, Lodziński P, Kiliszek M et al (2003) Nawrotny częstoskurcz węzłowy – czyli krótka rozprawa o zapętleniu się węzła przedsionkowo – komorowego. Kardiol po Dypl 2:68–72 Koźluk E, Lodziński P, Kiliszek M et al (2003) Nawrotny częstoskurcz węzłowy – czyli krótka rozprawa o zapętleniu się węzła przedsionkowo – komorowego. Kardiol po Dypl 2:68–72
8.
go back to reference Medkour D, Becker AE, Khalife K et al (1998) Anatomic and functional characteristics of a slow posterior AV nodal pathway: role in dual-pathway physiology and reentry. Circulation 98:164–174PubMed Medkour D, Becker AE, Khalife K et al (1998) Anatomic and functional characteristics of a slow posterior AV nodal pathway: role in dual-pathway physiology and reentry. Circulation 98:164–174PubMed
9.
go back to reference Deetjen A, Heidland A, Pangerl A et al (1995) Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients. Clin Nephrol 43:47–52PubMed Deetjen A, Heidland A, Pangerl A et al (1995) Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients. Clin Nephrol 43:47–52PubMed
10.
go back to reference Masumura H, Miki S, Kaifu Y et al (1992) Pharmacokinetics and efficacy of carvedilol in hypertensive patients with chronic renal failure and hemodialysis patients. J Cardiovasc Pharmacol 19(suppl 1):102–107CrossRef Masumura H, Miki S, Kaifu Y et al (1992) Pharmacokinetics and efficacy of carvedilol in hypertensive patients with chronic renal failure and hemodialysis patients. J Cardiovasc Pharmacol 19(suppl 1):102–107CrossRef
11.
go back to reference Miki S, Masumura H, Kaifu Y et al (1991) Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension. J Cardiovasc Pharmacol 18(suppl 4):62–68 Miki S, Masumura H, Kaifu Y et al (1991) Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension. J Cardiovasc Pharmacol 18(suppl 4):62–68
12.
go back to reference Kozłowski D, Koźluk E, Derejko P et al (2003) Conduction heterogeneity resulting in nonuniformity of atrioventricular nodal reentrant tachycardia—review on the base of a case report (Polish). Pol Przegl Kardiol 5:357–365 Kozłowski D, Koźluk E, Derejko P et al (2003) Conduction heterogeneity resulting in nonuniformity of atrioventricular nodal reentrant tachycardia—review on the base of a case report (Polish). Pol Przegl Kardiol 5:357–365
13.
go back to reference McGuire M, Bourke J, Robotin M et al (1993) High resolution mapping of Koch`s triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia. Circulation 88:2315–2328PubMed McGuire M, Bourke J, Robotin M et al (1993) High resolution mapping of Koch`s triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia. Circulation 88:2315–2328PubMed
14.
go back to reference Obergassel L, Weismuller P, Kattenbeck K et al (1999) Typical AV nodal reentry tachycardia in 4 anterograde AV nodal pathways. Successful high frequency ablation of slow AV nodal pathways. Med Klin 94:386–390CrossRef Obergassel L, Weismuller P, Kattenbeck K et al (1999) Typical AV nodal reentry tachycardia in 4 anterograde AV nodal pathways. Successful high frequency ablation of slow AV nodal pathways. Med Klin 94:386–390CrossRef
15.
go back to reference Sorbera C, Cohen M, Woolf P et al (2000) Atrioventricular nodal reentry tachycardia. Slow pathway ablation using the transseptal approach. PACE 23:1343–1349PubMed Sorbera C, Cohen M, Woolf P et al (2000) Atrioventricular nodal reentry tachycardia. Slow pathway ablation using the transseptal approach. PACE 23:1343–1349PubMed
16.
go back to reference Trusz-Gluza M (2005)Ablacja przezskórna. In: Szczeklik A (ed) Choroby Wewnętrzne, 1st edn. Kraków, Medycyna Praktyczna, pp 222–223 Trusz-Gluza M (2005)Ablacja przezskórna. In: Szczeklik A (ed) Choroby Wewnętrzne, 1st edn. Kraków, Medycyna Praktyczna, pp 222–223
Metadata
Title
Recurrent atrioventricular nodal re-entrant tachycardia treated with percutaneous ablation in a 75-year old patient undergoing intermittent hemodialysis
Authors
Aniela M. Ratajewska
Wojciech W. Banachowicz
Alicja E. Grzegorzewska
Publication date
01-03-2009
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2009
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-007-9302-y

Other articles of this Issue 1/2009

International Urology and Nephrology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.